Influenza Vaccination Market Report

Global Influenza Vaccination Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Mar 01, 2022
  • PAGES：180
  • REPORT CODE：GMM787961
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Influenza Vaccination market report explains the definition, types, applications, major countries, and major players of the Influenza Vaccination market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • F Hoffmann-La Roche Ltd (Europe)

    • Novartis AG (Europe)

    • Abbott (US)

    • AstraZeneca (Europe)

    • DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific)

    • GlaxoSmithKline plc (Europe)

    • Hualan Biological Engineering Inc (Asia Pacific)

    • BioCryst Pharmaceuticals Inc (US)

    • Mitsubishi Tanabe Pharma Corporation (Asia Pacific)

    • Sanofi (Europe)

    By Type:

    • Egg Based

    • Cell Culture

    • Recombinant

    By End-User:

    • Hospitals

    • Research Organizations

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Influenza Vaccination Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Influenza Vaccination Outlook to 2028- Original Forecasts

    • 2.2 Influenza Vaccination Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Influenza Vaccination Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Influenza Vaccination Market- Recent Developments

    • 6.1 Influenza Vaccination Market News and Developments

    • 6.2 Influenza Vaccination Market Deals Landscape

    7 Influenza Vaccination Raw Materials and Cost Structure Analysis

    • 7.1 Influenza Vaccination Key Raw Materials

    • 7.2 Influenza Vaccination Price Trend of Key Raw Materials

    • 7.3 Influenza Vaccination Key Suppliers of Raw Materials

    • 7.4 Influenza Vaccination Market Concentration Rate of Raw Materials

    • 7.5 Influenza Vaccination Cost Structure Analysis

      • 7.5.1 Influenza Vaccination Raw Materials Analysis

      • 7.5.2 Influenza Vaccination Labor Cost Analysis

      • 7.5.3 Influenza Vaccination Manufacturing Expenses Analysis

    8 Global Influenza Vaccination Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Influenza Vaccination Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Influenza Vaccination Export by Region (Top 10 Countries) (2017-2028)

    9 Global Influenza Vaccination Market Outlook by Types and Applications to 2022

    • 9.1 Global Influenza Vaccination Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Egg Based Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Cell Culture Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Recombinant Consumption and Growth Rate (2017-2022)

    • 9.2 Global Influenza Vaccination Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Research Organizations Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Influenza Vaccination Market Analysis and Outlook till 2022

    • 10.1 Global Influenza Vaccination Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Influenza Vaccination Consumption (2017-2022)

      • 10.2.2 Canada Influenza Vaccination Consumption (2017-2022)

      • 10.2.3 Mexico Influenza Vaccination Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Influenza Vaccination Consumption (2017-2022)

      • 10.3.2 UK Influenza Vaccination Consumption (2017-2022)

      • 10.3.3 Spain Influenza Vaccination Consumption (2017-2022)

      • 10.3.4 Belgium Influenza Vaccination Consumption (2017-2022)

      • 10.3.5 France Influenza Vaccination Consumption (2017-2022)

      • 10.3.6 Italy Influenza Vaccination Consumption (2017-2022)

      • 10.3.7 Denmark Influenza Vaccination Consumption (2017-2022)

      • 10.3.8 Finland Influenza Vaccination Consumption (2017-2022)

      • 10.3.9 Norway Influenza Vaccination Consumption (2017-2022)

      • 10.3.10 Sweden Influenza Vaccination Consumption (2017-2022)

      • 10.3.11 Poland Influenza Vaccination Consumption (2017-2022)

      • 10.3.12 Russia Influenza Vaccination Consumption (2017-2022)

      • 10.3.13 Turkey Influenza Vaccination Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Influenza Vaccination Consumption (2017-2022)

      • 10.4.2 Japan Influenza Vaccination Consumption (2017-2022)

      • 10.4.3 India Influenza Vaccination Consumption (2017-2022)

      • 10.4.4 South Korea Influenza Vaccination Consumption (2017-2022)

      • 10.4.5 Pakistan Influenza Vaccination Consumption (2017-2022)

      • 10.4.6 Bangladesh Influenza Vaccination Consumption (2017-2022)

      • 10.4.7 Indonesia Influenza Vaccination Consumption (2017-2022)

      • 10.4.8 Thailand Influenza Vaccination Consumption (2017-2022)

      • 10.4.9 Singapore Influenza Vaccination Consumption (2017-2022)

      • 10.4.10 Malaysia Influenza Vaccination Consumption (2017-2022)

      • 10.4.11 Philippines Influenza Vaccination Consumption (2017-2022)

      • 10.4.12 Vietnam Influenza Vaccination Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Influenza Vaccination Consumption (2017-2022)

      • 10.5.2 Colombia Influenza Vaccination Consumption (2017-2022)

      • 10.5.3 Chile Influenza Vaccination Consumption (2017-2022)

      • 10.5.4 Argentina Influenza Vaccination Consumption (2017-2022)

      • 10.5.5 Venezuela Influenza Vaccination Consumption (2017-2022)

      • 10.5.6 Peru Influenza Vaccination Consumption (2017-2022)

      • 10.5.7 Puerto Rico Influenza Vaccination Consumption (2017-2022)

      • 10.5.8 Ecuador Influenza Vaccination Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Influenza Vaccination Consumption (2017-2022)

      • 10.6.2 Kuwait Influenza Vaccination Consumption (2017-2022)

      • 10.6.3 Oman Influenza Vaccination Consumption (2017-2022)

      • 10.6.4 Qatar Influenza Vaccination Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Influenza Vaccination Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Influenza Vaccination Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Influenza Vaccination Consumption (2017-2022)

      • 10.7.2 South Africa Influenza Vaccination Consumption (2017-2022)

      • 10.7.3 Egypt Influenza Vaccination Consumption (2017-2022)

      • 10.7.4 Algeria Influenza Vaccination Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Influenza Vaccination Consumption (2017-2022)

      • 10.8.2 New Zealand Influenza Vaccination Consumption (2017-2022)

    11 Global Influenza Vaccination Competitive Analysis

    • 11.1 F Hoffmann-La Roche Ltd (Europe)

      • 11.1.1 F Hoffmann-La Roche Ltd (Europe) Company Details

      • 11.1.2 F Hoffmann-La Roche Ltd (Europe) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 F Hoffmann-La Roche Ltd (Europe) Influenza Vaccination Main Business and Markets Served

      • 11.1.4 F Hoffmann-La Roche Ltd (Europe) Influenza Vaccination Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Novartis AG (Europe)

      • 11.2.1 Novartis AG (Europe) Company Details

      • 11.2.2 Novartis AG (Europe) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Novartis AG (Europe) Influenza Vaccination Main Business and Markets Served

      • 11.2.4 Novartis AG (Europe) Influenza Vaccination Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Abbott (US)

      • 11.3.1 Abbott (US) Company Details

      • 11.3.2 Abbott (US) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Abbott (US) Influenza Vaccination Main Business and Markets Served

      • 11.3.4 Abbott (US) Influenza Vaccination Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 AstraZeneca (Europe)

      • 11.4.1 AstraZeneca (Europe) Company Details

      • 11.4.2 AstraZeneca (Europe) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 AstraZeneca (Europe) Influenza Vaccination Main Business and Markets Served

      • 11.4.4 AstraZeneca (Europe) Influenza Vaccination Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific)

      • 11.5.1 DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific) Company Details

      • 11.5.2 DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific) Influenza Vaccination Main Business and Markets Served

      • 11.5.4 DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific) Influenza Vaccination Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 GlaxoSmithKline plc (Europe)

      • 11.6.1 GlaxoSmithKline plc (Europe) Company Details

      • 11.6.2 GlaxoSmithKline plc (Europe) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 GlaxoSmithKline plc (Europe) Influenza Vaccination Main Business and Markets Served

      • 11.6.4 GlaxoSmithKline plc (Europe) Influenza Vaccination Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Hualan Biological Engineering Inc (Asia Pacific)

      • 11.7.1 Hualan Biological Engineering Inc (Asia Pacific) Company Details

      • 11.7.2 Hualan Biological Engineering Inc (Asia Pacific) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Hualan Biological Engineering Inc (Asia Pacific) Influenza Vaccination Main Business and Markets Served

      • 11.7.4 Hualan Biological Engineering Inc (Asia Pacific) Influenza Vaccination Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 BioCryst Pharmaceuticals Inc (US)

      • 11.8.1 BioCryst Pharmaceuticals Inc (US) Company Details

      • 11.8.2 BioCryst Pharmaceuticals Inc (US) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 BioCryst Pharmaceuticals Inc (US) Influenza Vaccination Main Business and Markets Served

      • 11.8.4 BioCryst Pharmaceuticals Inc (US) Influenza Vaccination Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Mitsubishi Tanabe Pharma Corporation (Asia Pacific)

      • 11.9.1 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Company Details

      • 11.9.2 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Influenza Vaccination Main Business and Markets Served

      • 11.9.4 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Influenza Vaccination Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Sanofi (Europe)

      • 11.10.1 Sanofi (Europe) Company Details

      • 11.10.2 Sanofi (Europe) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Sanofi (Europe) Influenza Vaccination Main Business and Markets Served

      • 11.10.4 Sanofi (Europe) Influenza Vaccination Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    12 Global Influenza Vaccination Market Outlook by Types and Applications to 2028

    • 12.1 Global Influenza Vaccination Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Egg Based Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Cell Culture Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Recombinant Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Influenza Vaccination Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Research Organizations Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Influenza Vaccination Market Analysis and Outlook to 2028

    • 13.1 Global Influenza Vaccination Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.2.2 Canada Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Influenza Vaccination Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.3.2 UK Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.3.3 Spain Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.3.5 France Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.3.6 Italy Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.3.8 Finland Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.3.9 Norway Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.3.11 Poland Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.3.12 Russia Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Influenza Vaccination Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.4.2 Japan Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.4.3 India Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Influenza Vaccination Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.5.3 Chile Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.5.6 Peru Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Influenza Vaccination Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.6.3 Oman Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Influenza Vaccination Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Influenza Vaccination Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Influenza Vaccination Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Influenza Vaccination Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Influenza Vaccination

    • Figure of Influenza Vaccination Picture

    • Table Global Influenza Vaccination Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Influenza Vaccination Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Egg Based Consumption and Growth Rate (2017-2022)

    • Figure Global Cell Culture Consumption and Growth Rate (2017-2022)

    • Figure Global Recombinant Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Research Organizations Consumption and Growth Rate (2017-2022)

    • Figure Global Influenza Vaccination Consumption by Country (2017-2022)

    • Table North America Influenza Vaccination Consumption by Country (2017-2022)

    • Figure United States Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure Canada Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure Mexico Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Table Europe Influenza Vaccination Consumption by Country (2017-2022)

    • Figure Germany Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure UK Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure Spain Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure Belgium Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure France Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure Italy Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure Denmark Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure Finland Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure Norway Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure Sweden Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure Poland Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure Russia Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure Turkey Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Table APAC Influenza Vaccination Consumption by Country (2017-2022)

    • Figure China Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure Japan Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure India Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure South Korea Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure Thailand Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure Singapore Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure Philippines Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Table South America Influenza Vaccination Consumption by Country (2017-2022)

    • Figure Brazil Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure Colombia Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure Chile Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure Argentina Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure Peru Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Table GCC Influenza Vaccination Consumption by Country (2017-2022)

    • Figure Bahrain Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure Oman Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure Qatar Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Table Africa Influenza Vaccination Consumption by Country (2017-2022)

    • Figure Nigeria Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure South Africa Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure Egypt Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure Algeria Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Table Oceania Influenza Vaccination Consumption by Country (2017-2022)

    • Figure Australia Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Table F Hoffmann-La Roche Ltd (Europe) Company Details

    • Table F Hoffmann-La Roche Ltd (Europe) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Ltd (Europe) Influenza Vaccination Main Business and Markets Served

    • Table F Hoffmann-La Roche Ltd (Europe) Influenza Vaccination Product Portfolio

    • Table Novartis AG (Europe) Company Details

    • Table Novartis AG (Europe) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG (Europe) Influenza Vaccination Main Business and Markets Served

    • Table Novartis AG (Europe) Influenza Vaccination Product Portfolio

    • Table Abbott (US) Company Details

    • Table Abbott (US) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott (US) Influenza Vaccination Main Business and Markets Served

    • Table Abbott (US) Influenza Vaccination Product Portfolio

    • Table AstraZeneca (Europe) Company Details

    • Table AstraZeneca (Europe) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca (Europe) Influenza Vaccination Main Business and Markets Served

    • Table AstraZeneca (Europe) Influenza Vaccination Product Portfolio

    • Table DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific) Company Details

    • Table DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

    • Table DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific) Influenza Vaccination Main Business and Markets Served

    • Table DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific) Influenza Vaccination Product Portfolio

    • Table GlaxoSmithKline plc (Europe) Company Details

    • Table GlaxoSmithKline plc (Europe) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline plc (Europe) Influenza Vaccination Main Business and Markets Served

    • Table GlaxoSmithKline plc (Europe) Influenza Vaccination Product Portfolio

    • Table Hualan Biological Engineering Inc (Asia Pacific) Company Details

    • Table Hualan Biological Engineering Inc (Asia Pacific) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hualan Biological Engineering Inc (Asia Pacific) Influenza Vaccination Main Business and Markets Served

    • Table Hualan Biological Engineering Inc (Asia Pacific) Influenza Vaccination Product Portfolio

    • Table BioCryst Pharmaceuticals Inc (US) Company Details

    • Table BioCryst Pharmaceuticals Inc (US) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioCryst Pharmaceuticals Inc (US) Influenza Vaccination Main Business and Markets Served

    • Table BioCryst Pharmaceuticals Inc (US) Influenza Vaccination Product Portfolio

    • Table Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Company Details

    • Table Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Influenza Vaccination Main Business and Markets Served

    • Table Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Influenza Vaccination Product Portfolio

    • Table Sanofi (Europe) Company Details

    • Table Sanofi (Europe) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi (Europe) Influenza Vaccination Main Business and Markets Served

    • Table Sanofi (Europe) Influenza Vaccination Product Portfolio

    • Figure Global Egg Based Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cell Culture Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Recombinant Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Research Organizations Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Influenza Vaccination Consumption Forecast by Country (2022-2028)

    • Table North America Influenza Vaccination Consumption Forecast by Country (2022-2028)

    • Figure United States Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Influenza Vaccination Consumption Forecast by Country (2022-2028)

    • Figure Germany Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Influenza Vaccination Consumption Forecast by Country (2022-2028)

    • Figure China Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Influenza Vaccination Consumption Forecast by Country (2022-2028)

    • Figure Brazil Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Influenza Vaccination Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Influenza Vaccination Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Influenza Vaccination Consumption Forecast by Country (2022-2028)

    • Figure Australia Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US